Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Doximity stock | $69.88

Learn how to easily invest in Doximity stock.

Doximity Inc. is a health information services business based in the US. Doximity shares (DOCS) are listed on the NYSE and all prices are listed in US Dollars. Doximity employs 749 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Doximity

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DOCS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Doximity stock price (NYSE: DOCS)

Use our graph to track the performance of DOCS stocks over time.

Doximity shares at a glance

Information last updated 2021-10-10.
Latest market close$69.88
52-week range$41.17 - $107.79
50-day moving average $88.47
200-day moving average $72.49
Wall St. target price$63.50
PE ratio 246.7742
Dividend yield N/A (0%)
Earnings per share (TTM) $0.31

Buy Doximity shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Doximity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Doximity price performance over time

Historical closes compared with the close of $69.88 from 2021-10-15

1 week (2021-10-08) -8.65%
1 month (2021-09-17) -26.96%
3 months (2021-07-16) 28.57%
6 months (2021-04-13) N/A
1 year (2020-10-13) N/A
2 years (2019-10-13) N/A
3 years (2018-10-13) N/A
5 years (2016-10-13) N/A

Is Doximity under- or over-valued?

Valuing Doximity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Doximity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Doximity's P/E ratio

Doximity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 247x. In other words, Doximity shares trade at around 247x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Doximity's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.

Doximity's EBITDA

Doximity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $77.6 million.

The EBITDA is a measure of a Doximity's overall financial performance and is widely used to measure a its profitability.

To put Doximity's EBITDA into context you can compare it against that of similar companies.

Doximity financials

Revenue TTM $243.2 million
Operating margin TTM 31.29%
Gross profit TTM $175.7 million
Return on assets TTM 17.06%
Return on equity TTM 43.51%
Profit margin 30.87%
Book value $3.93
Market capitalisation $14.2 billion

TTM: trailing 12 months

Shorting Doximity shares

There are currently 4.4 million Doximity shares held short by investors – that's known as Doximity's "short interest". This figure is 85.9% up from 2.3 million last month.

There are a few different ways that this level of interest in shorting Doximity shares can be evaluated.

Doximity's "short interest ratio" (SIR)

Doximity's "short interest ratio" (SIR) is the quantity of Doximity shares currently shorted divided by the average quantity of Doximity shares traded daily (recently around 2.4 million). Doximity's SIR currently stands at 1.85. In other words for every 100,000 Doximity shares traded daily on the market, roughly 1850 shares are currently held short.

To gain some more context, you can compare Doximity's short interest ratio against those of similar companies.

However Doximity's short interest can also be evaluated against the total number of Doximity shares, or, against the total number of tradable Doximity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Doximity's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Doximity shares in existence, roughly 20 shares are currently held short) or 0.0908% of the tradable shares (for every 100,000 tradable Doximity shares, roughly 91 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Doximity.

Find out more about how you can short Doximity stock.

Doximity share dividends

We're not expecting Doximity to pay a dividend over the next 12 months.

You may also wish to consider:

Doximity overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.

Frequently asked questions

What percentage of Doximity is owned by insiders or institutions?
Currently 0.202% of Doximity shares are held by insiders and 65.748% by institutions.
How many people work for Doximity?
Latest data suggests 749 work at Doximity.
When does the fiscal year end for Doximity?
Doximity's fiscal year ends in March.
Where is Doximity based?
Doximity's address is: 500, 3rd Street, San Francisco, CA, United States, 94107
What is Doximity's ISIN number?
Doximity's international securities identification number is: US26622P1075

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site